Aap Implantate AG Refines 2026 Forecast and Unveils 2027 Outlook

aap Implantate AG has refined its 2026 forecast and released its first outlook for 2027. For 2026, the company expects revenue between EUR 12.0 million and EUR 13.0 million, with EBITDA ranging from EUR -0.5 million to EUR +0.5 million. This follows a Q3 revenue of EUR 3.3 million and an EBITDA above the IFRS break-even point for the first nine months.

For 2027, revenue is projected to exceed EUR 14 million, with an EBITDA between EUR 0.0 million and EUR 2.0 million. The forecast aligns with plans for double-digit growth, driven by expanded sales and product offerings. By 2030, the company aims for revenue of at least EUR 21 million and an EBITDA margin of 17.5% to 22.5%, supported by increased production efficiency and international expansion.

Investors can access a detailed presentation on the company's website, and plans will be discussed at the Munich Capital Markets Conference. The company remains focused on solidifying its growth trajectory through strategic initiatives in sales and manufacturing.